CN Stock MarketDetailed Quotes

002437 Harbin Gloria Pharmaceuticals

Watchlist
  • 2.86
  • -0.07-2.39%
Market Closed Dec 13 15:00 CST
6.52BMarket Cap81.71P/E (TTM)

Harbin Gloria Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
维生素类药物531.92M43.55%
Cardio-cerebrovascular drugs356.43M29.18%
Orthopedic drugs137.88M11.29%
Antitumor drugs73.21M5.99%
Electrolyte drugs68M5.57%
Antiinfective drugs21.32M1.75%
其他用药领域15.56M1.27%
Nephrotic drugs7.76M0.64%
Digestive system drugs6.73M0.55%
Other2.5M0.21%
View all
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
化药行业1.12B92.02%
Traditional Chinese medicine industry94.93M7.77%
Other industries2.5M0.21%
Other----
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
Domestic1.22B99.85%
Abroad1.88M0.15%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Participate in the New Third Board
Participate in the New Third Board
Intraday-1.78%
Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.92%